Literature DB >> 11834523

Involvement of rho-kinase in agonists-induced contractions of arteriosclerotic human arteries.

Tadashi Kandabashi1, Hiroaki Shimokawa, Yasushi Mukai, Tetsuya Matoba, Ikuko Kunihiro, Keiko Morikawa, Masaaki Ito, Shosuke Takahashi, Kozo Kaibuchi, Akira Takeshita.   

Abstract

Coronary artery spasm plays an important role in the pathogenesis of a wide variety of ischemic heart diseases. We have recently demonstrated that Rho-kinase plays a key role in the spasm in our porcine model. However, it remains to be elucidated whether Rho-kinase-mediated pathway also contributes to vasoconstriction of human arteries. From 15 patients who underwent coronary artery bypass operation, segments of isolated left internal thoracic arteries were obtained, and the endothelium was gently removed. Serotonin and histamine caused contractions, which were markedly inhibited by a specific Rho-kinase inhibitor, hydroxyfasudil. Western blot analysis showed that, during the serotonin-induced contractions, the extent of phosphorylation of myosin-binding subunit of myosin phosphatase (MBS, one of the major substrates of Rho-kinase) was significantly increased in the specimens. Hydroxyfasudil again significantly suppressed the serotonin-induced increase in MBS phosphorylation. There was a significant positive correlation between the extent of MBS phosphorylation and that of the serotonin-induced contractions and between hydroxyfasudil-sensitive components of the contractions and the extent of arteriosclerosis. These results indicate that Rho-kinase plays an important role in vascular smooth muscle contractions of arteriosclerotic human arteries, suggesting that Rho-kinase could be regarded as an important target for the treatment of arteriosclerotic vascular diseases in humans.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11834523     DOI: 10.1161/hq0202.104274

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  15 in total

1.  Characteristics of the actions by which 5-hydroxytryptamine affects electrical and mechanical activities in rabbit jugular vein graft.

Authors:  Takashi Maekawa; Kimihiro Komori; Junko Kajikuri; Takeo Itoh
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

Review 2.  Pathogenesis of Systemic Sclerosis.

Authors:  Debendra Pattanaik; Monica Brown; Bradley C Postlethwaite; Arnold E Postlethwaite
Journal:  Front Immunol       Date:  2015-06-08       Impact factor: 7.561

Review 3.  Possible roles of 5-HT in vein graft failure due to intimal hyperplasia 5-HT, nitric oxide and vein graft.

Authors:  Akio Kodama; Takeo Itoh; Kimihiro Komori
Journal:  Surg Today       Date:  2013-03-28       Impact factor: 2.549

4.  PSGL-1 and mTOR regulate translation of ROCK-1 and physiological functions of macrophages.

Authors:  Richard Fox; Thomas Q Nhan; G Lynn Law; David R Morris; W Conrad Liles; Stephen M Schwartz
Journal:  EMBO J       Date:  2007-01-24       Impact factor: 11.598

5.  Rho kinase inhibitor fasudil mitigates high-cholesterol diet-induced hypercholesterolemia and vascular damage.

Authors:  Nibrass Taher Abdali; Awny H Yaseen; Eman Said; Tarek M Ibrahim
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-01-18       Impact factor: 3.000

Review 6.  Rho-kinase inhibition: a novel therapeutic target for the treatment of cardiovascular diseases.

Authors:  Ming Dong; Bryan P Yan; James K Liao; Yat-Yin Lam; Gabriel W K Yip; Cheuk-Man Yu
Journal:  Drug Discov Today       Date:  2010-06-25       Impact factor: 7.851

7.  c-Src tyrosine kinase, a critical component for 5-HT2A receptor-mediated contraction in rat aorta.

Authors:  Rong Lu; Abderrahmane Alioua; Yogesh Kumar; Pallob Kundu; Mansoureh Eghbali; Noelia V Weisstaub; Jay A Gingrich; Enrico Stefani; Ligia Toro
Journal:  J Physiol       Date:  2008-07-03       Impact factor: 5.182

8.  Endothelin-1 and endothelin-2 initiate and maintain contractile responses by different mechanisms in rat mesenteric and cerebral arteries.

Authors:  M G Compeer; G M J Janssen; J G R De Mey
Journal:  Br J Pharmacol       Date:  2013-11       Impact factor: 8.739

9.  Distinct effects of contraction agonists on the phosphorylation state of cofilin in pulmonary artery smooth muscle.

Authors:  Yan-Ping Dai; Shaner Bongalon; Violeta N Mutafova-Yambolieva; Ilia A Yamboliev
Journal:  Adv Pharmacol Sci       Date:  2007-11-06

10.  Association analysis of polymorphisms in ROCK2 with cardiovascular disease in a Chinese population.

Authors:  Lei Liu; Yanyan Cao; Guanglin Cui; Zongzhe Li; Jing Sun; Lina Zhang; Chen Chen; Yan Wang; Peihua Wang; Hu Ding; Dao Wen Wang
Journal:  PLoS One       Date:  2013-01-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.